GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avinger Inc (NAS:AVGR) » Definitions » 12-1 Month Momentum %

Avinger (Avinger) 12-1 Month Momentum % : -58.31% (As of May. 24, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Avinger 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-24), Avinger's 12-1 Month Momentum % is -58.31%.

The industry rank for Avinger's 12-1 Month Momentum % or its related term are showing as below:

AVGR's 12-1 Month Momentum % is ranked worse than
85.23% of 853 companies
in the Medical Devices & Instruments industry
Industry Median: -20.38 vs AVGR: -58.31

Competitive Comparison of Avinger's 12-1 Month Momentum %

For the Medical Instruments & Supplies subindustry, Avinger's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avinger's 12-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avinger's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Avinger's 12-1 Month Momentum % falls into.



Avinger  (NAS:AVGR) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avinger  (NAS:AVGR) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Avinger 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Avinger's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Avinger (Avinger) Business Description

Traded in Other Exchanges
N/A
Address
400 Chesapeake Drive, Redwood City, CA, USA, 94063
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO) and Pantheris, image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
Executives
Crg Partners Iii (cayman) Unlev Aiv I L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii (cayman) Lev Aiv I L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii - Parallel Fund B (cayman) L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Cr Group L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii - Parallel Fund (a) L.p. 10 percent owner C/O CAPITAL ROYALTY L.P., 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Nabeel Paul Subainati officer: Vice President, Finance 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
James Cullen director 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Mark Weinswig officer: Chief Financial Officer EMCORE CORP, 10420 RESEARCH ROAD, SE, ALBUQUERQUE NM 87123
Himanshu Patel officer: Chief Technology Officer C/O AVINGER, INC., 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
Jeffrey M Soinski director, officer: President and CEO 585 WEST 500 SOUTH, BOUNTIFUL UT 84010
Tamara Elias director 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
Simpson John B Ph D Md director, 10 percent owner C/O FOXHOLLOW TECHNOLOGIES, INC., 740 BAY ROAD, REDWOOD CITY CA 94063
Matthew Ferguson officer: CBO, CFO & Treasurer C/O FOXHOLLOW TECHNOLOGIES, INC., 740 BAY ROAD, REDWOOD CITY CA 94063
John D. Simpson officer: Sr. VP, Sales & Marketing C/O AVINGER, INC., 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063